37
Views
0
CrossRef citations to date
0
Altmetric
Miscellaneous

Correspondence

Pages 690-697 | Published online: 09 Jul 2010

References

  • Taylor A T. Catatonia: a review of a behavioural neurological syndrome. Neuropsychiatry, Neuropsychology, and Behavioural Neurology 1990; 3: 48–72
  • Regestein Q R, Alpert J S, Reich P. Sudden catatonic stupor with disastrous outcome. Journal of the American Medical Association 1977; 238: 618–620
  • Mahendra B. Editorial: Where have all the catatonics gone?. Psychological Medicine 1981; 11: 669–671
  • Abrams R, Taylor M A. Catatonia: Prediction of response to somatic treatments. American Journal of Psychiatry 1977; 134: 78–80
  • Rosebush P I, Hildebrand A M, Furlong B G, et al. Catatonic syndrome in a general psychiatric inpatient population: frequency, clinical presentation, and response to lorazepam. Journal of Clinical Psychiatry 1990; 51: 357–362
  • McEvoy J P, Lohr J B. Diazepam for catatonia. American Journal of Psychiatry 1984; 141: 284–285
  • Greenfeld D, Conrad C, Kincare P, Bowers M B. Treatment of catatonia with low-dose lorazepam. American Journal of Psychiatry 1987; 144: 1224–1225
  • Gelenberg A J, Mandel M R. Catatonic reaction to high-potency neuroleptic drugs. Archives of General Psychiatry 1977; 34: 947–950
  • Fink M, Taylor M A. Catatonia: a separate category in DSM-IV. Integrative Psychiatry 1991; 7: 2–10
  • Bowlby J. Attachment (Vol. 1). Pelican, MiddlesexUK 1971
  • Meares R. The persecutory therapist in the pursuit of intimacy. Nelson, Melbourne, Vic 1977
  • Rogeness G A, Javors M A, Pliszka S R. Neurochemistry and child and adolescent psychiatry. Journal of the American Academy of Child and Adolescent Psychiatry 1992; 31: 765–781
  • Salkovskis P M, Atha C, Storer D. Cognitive behavioural problem solving in the treatment of patients who repeatedly attempt suicide: a controlled trial. British Journal of Psychiatry 1990; 157: 871–876
  • House A, Owens D, Storer D. Psycho-social intervention following attempted suicide: is there a case for better services?. International Review of Psychiatry 1992; 4: 15–22
  • Gunnell D, Frankel S. Prevention of suicide: aspirations and evidence. British Medical Journal 1994; 308: 1227–1233
  • Lipinski J F, Mallya G, Zimmerman P, Pope H G. Fluoxetine-induced akathisia: Clinical and theoretical implications. Journal of Clinical Psychiatry 1989; 50: 339–342
  • Meltzer H Y, Matsubara S, Lee J C. Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin-2 pKi values. Journal of Pharmacology and Experimental Therapeutics 1989; 251: 238–246
  • Bernick C. Methysergide-induced akathisia. Clinical Neuropharmacology 1988; 11: 87–89
  • Kramer M S, DiJohnson C, Davis P, et al. L-tryptophan in neuroleptic-induced akathisia. Biological Psychiatry 1990; 27: 671–672
  • Ugedo L, Grenhoff J, Svensson T H. Ritanserin, a 5-HT2 receptor antagonist, activates midbrain dopamine neurons by blocking serotonergic inhibition. Psychopharmacology 1989; 98: 45–50
  • Blandina P, Goldfarb J, Green J P. Activation of a 5-HT3 receptor releases dopamine from rat striatal slice. European Journal of Pharmacology 1988; 155: 349–350
  • Waddington J L. Schizophrenia, affective psychoses and other disorders treated with neuroleptic drugs: The enigma of tardive dyskinesia, its neurobiological determinants and the conflict of paradigms. Intenational Review of Neuroscience 1989; 31: 297–353
  • Casey D E. Spontaneous and tardive dyskinesia: Clinical and laboratory studies. Journal of Clinical Psychiatry 1985; 46: 42–47
  • Ayd F J. A survey of drug-induced extrapyramidal reactions. Journal of the American Medical Association 1961; 175: 1054–1060
  • Sachdev P. Depression-dependent exacerbation of tardive dyskinesia. British Journal of Psychiatry 1989; 155: 253–255
  • Reynolds G P, Brown J E, McCall J C, MacKay A VP. Dopamine receptor abnormalities in the striatum and pallidum in tardive dyskinesia: a post morlem study. Journal of Neural Transmission 1992; 87: 225–230
  • Lewander T, Westerbergh S-E, Morrison D. Clinical profile of remoxipride - a combined analysis of a comparative double blind, multicentre trial programme. Acta Psychiatrica Scandinavica 1990; 82: 92–98
  • Arya D K, Szabadie E. Dyskinesia associated with fluvoxamine. (Letter) Journal of Clinical Psychopharmacology 1993; 13: 365–366
  • Mander A G, McCausland B, Workman B, Flamer H, Christophidis N. Fluoxetine induced dyskinesia. Australian and New Zealand Journal of Psychiatry 1994; 28: 328–330
  • Hunter E. Aboriginal suicides in custody: A view from the Kimberley. Australian and New Zealand Journal of Psychiatry 1988; 22: 273–282
  • Hunter E. On Gordian knots and nooses: Aboriginal suicide in the Kimberley. Australian and New Zealand Journal of Psychiatry 1988; 22: 264–271
  • Meggitt M J. Desert people: A study of the Walpiri Aborigines of Central Australia. Angus and Robertson, Sydney 1962
  • Elkin A P. The Australian Aborigines: How to understand them. Angus and Robertson, Sydney 1945
  • Hart C WM, Pilling A R, Goodale J C. The Tiwi of North Australia, 3rd edition. Holt, Rinehart and Winston, New York 1988
  • Eastwell H. The low risk of suicide amongst the Yolngu of the Northern Territory: the traditional Aboriginal pattern. Medical Journal of Australia 1988; 148: 338–340
  • Jones I, de L Home D J. Diagnosis of psychiatric illness among tribal Aborigines. Medical Journal of Australia 1972; 1: 345–349

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.